Literature DB >> 3930269

Role of prostanoids in the protective actions of BW755C on the gastric mucosa.

J L Wallace, B J Whittle.   

Abstract

The ability of BW755C to reduce ethanol- or indomethacin-induced gastric damage and the role of prostanoids in the mechanism of this action were examined in the rat. BW755C (1-100 mg/kg) caused a dose-related reduction in the amount of damage produced by oral administration of 40% ethanol in 100 mM HCl. At the doses tested, BW755C had no significant effect on mucosal 6-keto-prostaglandin F1 alpha synthesis, but did cause a dose-dependent reduction in thromboxane B2 synthesis. The effect on thromboxane synthesis may be due to a selective inhibition of platelet cyclo-oxygenase by BW755C. The higher doses of BW755C (50 and 100 mg/kg) caused a significant increase in the volume of fluid present in the gastric lumen, which may contribute to the protective action of the drug against ethanol-induced damage. Oral administration of BW755C (50 mg/kg) significantly reduced the extent of gastric damage caused by subcutaneous injection of indomethacin (20 mg/kg) indicating that it is unlikely that the protective action of BW755C is mediated by endogenous prostanoids. The mechanism of the protective actions of BW755C may be related to its reported ability to inhibit lipoxygenase or to its actions as a free-radical scavenger.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930269     DOI: 10.1016/0014-2999(85)90582-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Comparison of the ulcerogenic properties of tepoxalin with those of non-steroidal anti-inflammatory drugs (NSAIDs).

Authors:  J L Wallace; G Cirino; C Cicala; D W Anderson; D Argentieri; R J Capetola
Journal:  Agents Actions       Date:  1991-09

2.  Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.

Authors:  J L Wallace; B J Whittle
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

3.  Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone.

Authors:  J L Wallace; B J Whittle
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

4.  The effects of the stable thromboxane A2-mimetic, U46619, on gastric mucosal damage and gastric non-parietal secretion in the rat.

Authors:  K T Bunce; N M Clayton
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

5.  The protective mechanism of FPL55712 against stress-induced gastric ulceration in rats.

Authors:  C W Ogle; C H Cho
Journal:  Agents Actions       Date:  1989-03

6.  Eicosanoid synthesis in duodenal ulcer disease: decrease in leukotriene C4 by colloidal bismuth subcitrate.

Authors:  A Ahmed; P R Salmon; C R Cairns; M Hobsley; J R Hoult
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

7.  Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs.

Authors:  N Hudson; M Balsitis; S Everitt; C J Hawkey
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

8.  Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats.

Authors:  S J Konturek; T Brzozowski; D Drozdowicz; G Beck
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

9.  Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy.

Authors:  P M Vaananen; C M Keenan; M B Grisham; J L Wallace
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

10.  Leukotrienes do not contribute to the pathogenesis of indomethacin-induced ulceration of the gastric antrum in the re-fed rat.

Authors:  M A Trevethick; N M Clayton; A K Bahl; P Strong; I W Harman
Journal:  Agents Actions       Date:  1994-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.